Cellectis SA ã¯èšåºæ®µéã®ãã€ãªãã¯ãããžãŒäŒæ¥ã§ããã现èãæšçã«ããŠæ ¹çµ¶ãããã¡ã©æåå容äœãçºçŸããéºäŒåç·šé T 现èã«åºã¥ãå
ç«è
«ç補åãéçºããŠããŸããåç€Ÿã¯æ²»çéšéãšæ€ç©éšéã® 2 ã€ã®éšéã§äºæ¥ãå±éããŠããŸããå瀟ã¯ãæ¥æ§ãªã³ãæ§çœè¡ç
ãªã©ã® CD19 çºçŸè¡æ¶²æªæ§è
«çã®æ²»çãç®çãšããåçš® T 现è補ååè£ UCART19ãåçºæ§/飿²»æ§ã³ãŸãæ§å€§çްèå B 现èãªã³ãè
«ããã³æ¿Ÿèæ§ãªã³ãè
«ã®æ²»çãç®çãšãã ALLO-501 ããã³ ALLO-501Aãè
现èããã®æ²»çãç®çãšãã ALLO-316ãæ¥æ§éªšé«æ§çœè¡ç
ã®æ²»çãç®çãšãã UCART123ãããã³ B çŽ°èæ¥æ§ãªã³ãæ§çœè¡ç
ã®æ²»çãç®çãšãã UCART22 ãéçºããŠããŸããå瀟ã¯ãŸããå€çºæ§éªšé«è
«ã®æ²»çè¬ UCARTCS1 ããã³ ALLO-715 ã®éçºãè¡ã£ãŠããŸããããã«ãå瀟ã¯é«ãªã¬ã€ã³é
žå€§è±æ²¹ããã®ä»ã®å€§è±è£œåãç¹ç¶çšå°éºŠãçç£ããŠããŸããå瀟㯠Allogene Therapeutics, Inc.ãLes Laboratoires Servierããããµã¹å€§åŠ MD ã¢ã³ããŒãœã³ããã»ã³ã¿ãŒãIovance Biotherapeutics ãšæŠç¥çææºãçµãã§ããã»ããCytovia Therapeutics, Inc. ãšæŠç¥çç ç©¶éçºææºãçµãã§ããŸããå瀟㯠1999 幎ã«èšç«ãããæ¬ç€Ÿã¯ãã©ã³ã¹ã®ããªã«ãããŸãã